Skip to main content
Top
Published in: Supportive Care in Cancer 5/2009

01-05-2009 | Supportive Care International

The Medical Care Continuity (MCC) project. A pilot study of video-assisted home care within the eTEN European Community program. The Italian experience

Authors: V. Formica, E. Fossile, R. Pellegrino, M. Fatale, M. Mari, M. Rabuffetti, F. R. Benedetto, G. Visconti, E. Bollero, M. Roselli

Published in: Supportive Care in Cancer | Issue 5/2009

Login to get access

Abstract

Goals of work

This study aimed to use an integrated system (Medical Care Continuity (MCC) system) consisting of computer, video telephone, and a high-definition camera to monitor at home chemotherapy side effects in cancer outpatients.

Patients and methods

The system allowed 24 h/day video consultation with an intermediate medical call center with possible connection to a specialized hospital if necessary. All patients were provided with internationally validated and project-oriented questionnaires exploring patients’ health status and opinions on usefulness and complexity of study devices. The content of each call was recorded on a computer database. An approximate estimate of avoided hospital admissions was calculated.

Main results

Median duration of experimentation and frequency of patient/doctor contacts were 2.1 months and 4.2 contact per week, respectively. Overall, a 98% positive opinions on the experimental system was reported at the end of the study by all participants, with a 21% conversion rate with respect to the opinions gathered at study entry. Changes in patient management after a medical call were made in 32% of cases. It was calculated that approximately 2.2 per month unnecessary hospital admissions were avoided.

Conclusions

The MCC system was well managed by both patients and caregivers. These results show that it has the potential to improve medical assistance by virtue of a constant access to medical advice and reduce unnecessary hospital admissions.
Literature
1.
go back to reference Berard RM (2001) Depression and anxiety in oncology the psychiatrist’s perspective. J Clin Psychiatry 62:58–61PubMed Berard RM (2001) Depression and anxiety in oncology the psychiatrist’s perspective. J Clin Psychiatry 62:58–61PubMed
4.
go back to reference Cassidy J, Twelves C, Van Cutsem E, Hoff P, Bajetta E, Boyer M et al (2002) Capecitabine Colorectal Cancer Study Group: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin. Ann Oncol 13:566–575. doi:10.1093/annonc/mdf089 PubMedCrossRef Cassidy J, Twelves C, Van Cutsem E, Hoff P, Bajetta E, Boyer M et al (2002) Capecitabine Colorectal Cancer Study Group: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin. Ann Oncol 13:566–575. doi:10.​1093/​annonc/​mdf089 PubMedCrossRef
5.
go back to reference Chumbler NR, Kobb R, Harris L, Richardson LC, Darkins A, Sberna M et al (2007) Healthcare utilization among veterans undergoing chemotherapy: the impact of a cancer care coordination/home-telehealth program. J Ambul Care Manage 30:308–317PubMed Chumbler NR, Kobb R, Harris L, Richardson LC, Darkins A, Sberna M et al (2007) Healthcare utilization among veterans undergoing chemotherapy: the impact of a cancer care coordination/home-telehealth program. J Ambul Care Manage 30:308–317PubMed
6.
go back to reference Dowd S, Davidhizar R (1999) Opening up to the Katz index. Elder Care 11:9–12PubMed Dowd S, Davidhizar R (1999) Opening up to the Katz index. Elder Care 11:9–12PubMed
9.
go back to reference Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, pp 199–205 Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, pp 199–205
10.
go back to reference Kunkler IH, Prescott RJ, Lee RJ, Brebner JA, Cairns JA, Fielding RG, Bowman A, Neades G, Walls AD, Chetty U, Dixon JM, Smith ME, Gardner TW, Macnab M, Swann S, Maclean (2007) TELEMAM: a cluster randomised trial to assess the use of telemedicine in multi-disciplinary breast cancer decision making. Eur J Cancer 43:2506–2514. doi:10.1016/j.ejca.2007.08.026 PubMedCrossRef Kunkler IH, Prescott RJ, Lee RJ, Brebner JA, Cairns JA, Fielding RG, Bowman A, Neades G, Walls AD, Chetty U, Dixon JM, Smith ME, Gardner TW, Macnab M, Swann S, Maclean (2007) TELEMAM: a cluster randomised trial to assess the use of telemedicine in multi-disciplinary breast cancer decision making. Eur J Cancer 43:2506–2514. doi:10.​1016/​j.​ejca.​2007.​08.​026 PubMedCrossRef
15.
go back to reference Purkable TL, Bauer JJ (1999) A telementored trans-rectal ultrasound guided prostate biopsy. Stud Health Technol Inform 62:275–277PubMed Purkable TL, Bauer JJ (1999) A telementored trans-rectal ultrasound guided prostate biopsy. Stud Health Technol Inform 62:275–277PubMed
16.
go back to reference Smith TJ, Khatcheressian J, Lyman GH, Ozer H, Armitage JO, Balducci L et al (2006) 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol 24:3187–3205. doi:10.1200/JCO.2006.06.4451 PubMedCrossRef Smith TJ, Khatcheressian J, Lyman GH, Ozer H, Armitage JO, Balducci L et al (2006) 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol 24:3187–3205. doi:10.​1200/​JCO.​2006.​06.​4451 PubMedCrossRef
Metadata
Title
The Medical Care Continuity (MCC) project. A pilot study of video-assisted home care within the eTEN European Community program. The Italian experience
Authors
V. Formica
E. Fossile
R. Pellegrino
M. Fatale
M. Mari
M. Rabuffetti
F. R. Benedetto
G. Visconti
E. Bollero
M. Roselli
Publication date
01-05-2009
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 5/2009
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-008-0559-1

Other articles of this Issue 5/2009

Supportive Care in Cancer 5/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine